Insulet Corporation
NASDAQ:PODDMedical - Devices
-$4.17 today
- Market cap
- $9.71B
- Beta
- 1.13
- P/E (TTM)
- 33.2
- EPS (TTM)
- $4.33
Volume 2.09M
Average 1.32M
PODD Net Income
Bottom-line profit, the starting point for calculating cash from operations.
Insulet CorporationNASDAQ: PODD
Net Income · Q2 FY2026 · quarter ended Jun 2026
Net income growth accelerates
Q2 FY2026 net income of $95M rose 322.2% year over year, ahead of the +59.0% change in trailing-twelve-month net income. Sequentially, it rose 4.3% from the prior quarter. Over 3 fiscal years it compounded at +277.3% a year.
Context
- Net income amounted to 9.1% of revenue in FY2025, down 11.1 pp from a year earlier.
- Net income increased in 2 of the last 3 fiscal years.
What to watch
Whether net income reaches the consensus estimate from 19 analysts of $489.48M (+98.1%) for the fiscal year ending Dec 2026, a step up from the -40.9% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $95M+4.3% QoQ
- Last fiscal yearDec 2025
- $247.1M-40.9% YoY
- LTMJun 2026
- $375.3M+59.0% YoY
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- 247.1M USD
- Year-over-year change
- -40.9%
- 4-year CAGR
- +95.8%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 247.1M | -40.9% |
| FY2024 | 2024-12-31 | 418.3M | +102.8% |
| FY2023 | 2023-12-31 | 206.3M | +4384.8% |
| FY2022 | 2022-12-31 | 4.6M | -72.6% |
| FY2021 | 2021-12-31 | 16.8M | — |
Net Income vs competitors
How PODD compares with its peers on the latest reported figures
- PODD's LTM Jun 2026 net income of $375.3M is the 2nd largest of the 5 companies compared; the peer median is $76.81M.
- Its year-over-year change of +59.0% is the 2nd highest of 5, against a peer median of +5.7%.
- Net income amounts to 12.3% of revenue for PODD, versus a peer median of 40.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $999.7M | +74.9% | +34.8% | 20.1% | |
| LTM Jun 2026 | $375.3M | +59.0% | +277.3% | 12.3% | |
| LTM Mar 2026 | $94.55M | -48.6% | +29.3% | 9.2% | |
| LTM Mar 2026 | $87.19M | +17.8% | — | 214.2% | |
| LTM Mar 2026 | $66.44M | -6.4% | +4.2% | 60.3% | |
| Peer median (excluding PODD) | $76.81M | +5.7% | +29.3% | 40.2% | |
Competitors are the stored peer set for PODD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 16.8M | 4.6M | 206.3M | 418.3M | 247.1M |
| Depreciation & Amortization | 57.4M | 63.2M | 72.8M | 80.8M | 90.4M |
| Deferred Income Tax | 0 | (1M) | 500K | (136.9M) | 62.2M |
| Stock-Based Compensation | 34.4M | 40.9M | 48.3M | 69.3M | 62.7M |
| Change in Working Capital | (263.6M) | (2.5M) | (190.6M) | (17M) | (23.1M) |
| Accounts Receivables | (71.3M) | (51.8M) | (154.2M) | (10.4M) | (140.2M) |
| Inventory | (154.4M) | (49.1M) | (53.6M) | (32.4M) | (10.6M) |
| Accounts Payables | (15.6M) | (2.4M) | (11M) | 2.2M | 49.2M |
| Other Working Capital | (22.3M) | 100.8M | 28.2M | 23.6M | 78.5M |
| Other Non-Cash Items | 86.9M | 13.8M | 8.4M | 15.8M | 130M |
| Operating Cash Flow | (68.1M) | 119M | 145.7M | 430.3M | 569.3M |
| Capital Expenditures | (122.7M) | (157.3M) | (75.6M) | (124.9M) | (191.6M) |
| Acquisitions (Net) | 0 | (26M) | (3M) | 0 | 0 |
| Purchases of Investments | 0 | (7.8M) | (7.2M) | (12.2M) | 0 |
| Sales of Investments | 40M | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | (31.1M) |
| Investing Cash Flow | (82.7M) | (191.1M) | (119.4M) | (146.2M) | (222.7M) |
| Debt Repayment | 49.4M | (39.8M) | (27M) | (40.6M) | (708.1M) |
| Common Stock Issued | 23.5M | 16.3M | 26.9M | 20.1M | 33.9M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | (59.6M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (32.2M) | (16.8M) | (13.5M) | (7.6M) | 138.5M |
| Financing Cash Flow | 40.7M | (40.3M) | (13.6M) | (28.1M) | (595.3M) |
| Effect of Forex Changes | (5.5M) | (4.3M) | 1.8M | (6.8M) | 11.5M |
| Net Change in Cash | (115.6M) | (116.7M) | 14.5M | 249.2M | (237.3M) |
| Free Cash Flow | (190.8M) | (38.3M) | 70.1M | 305.4M | 377.7M |
Insulet Corporation
NASDAQ:PODD
Intrinsic Alpha fair value
Locked
Current Price
$139.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.